Corient Capital Partners, LLC Astrazeneca PLC Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Corient Capital Partners, LLC holds 13,966 shares of AZN stock, worth $897,455. This represents 0.07% of its overall portfolio holdings.

Number of Shares

13,966

Previous 11,648 19.9%

Holding current value

$897,455

Previous $770,000 19.87%

% of portfolio

0.07%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $122,900 - $314,668	2,318 Added 19.9%	13,966 $923,000
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $1.51 Million - $1.81 Million	-25,417 Reduced 68.57%	11,648 $770,000
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $117,179 - $141,153	-2,103 Reduced 5.37%	37,065 $2.46 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $399,639 - $472,214	-7,398 Reduced 15.89%	39,168 $2.28 Million
Q3 2021 Nov 16, 2021	BUY	$55.56 - $60.79 $198,793 - $217,506	3,578 Added 8.32%	46,566 $2.8 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $1,791 - $2,226	-37 Reduced 0.09%	42,988 $2.58 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $964,516 - $1.11 Million	-20,452 Reduced 32.22%	43,025 $2.14 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $317,466 - $379,624	6,543 Added 11.49%	63,477 $3.17 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $114,312 - $131,609	-2,154 Reduced 3.65%	56,934 $3.12 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $221,878 - $284,735	5,148 Added 9.54%	59,088 $3.13 Million
Q1 2020 May 06, 2020	BUY	$37.79 - $51.33 $64,318 - $87,363	1,702 Added 3.26%	53,940 $2.41 Million
Q4 2019 Feb 04, 2020	BUY	$42.46 - $50.46 $32,694 - $38,854	770 Added 1.5%	52,238 $2.6 Million
Q3 2019 Nov 06, 2019	BUY	$40.12 - $45.47 $274,300 - $310,878	6,837 Added 15.32%	51,468 $2.29 Million
Q2 2019 Aug 08, 2019	BUY	$37.28 - $41.68 $87,309 - $97,614	2,342 Added 5.54%	44,631 $1.84 Million
Q1 2019 May 10, 2019	SELL	$35.49 - $43.02 $127,160 - $154,140	-3,583 Reduced 7.81%	42,289 $1.71 Million
Q4 2018 Feb 07, 2019	SELL	$36.86 - $41.49 $1.51 Million - $1.7 Million	-41,037 Reduced 47.22%	45,872 $1.74 Million
Q2 2018 Oct 02, 2018	SELL	$34.55 - $37.05 $1.72 Million - $1.85 Million	-49,826 Reduced 36.44%	86,909 $3.05 Million
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $682,479 - $758,241	-20,700 Reduced 13.15%	136,735 $4.78 Million
Q4 2017 Feb 13, 2018	BUY	$32.09 - $34.78 $206,691 - $224,017	6,441 Added 4.27%	157,435 $5.46 Million
Q3 2017 Nov 14, 2017	SELL	$28.96 - $34.0 $417,892 - $490,620	-14,430 Reduced 8.72%	150,994 $0
Q2 2017 Aug 14, 2017	SELL	N/A	-7,171 Reduced 4.15%	165,424 $5.64 Million
Q1 2017 Aug 17, 2017	BUY	N/A	169,837 Added 6157.98%	172,595 $5.38 Million
Q1 2017 Aug 14, 2017	BUY	N/A	2,758	2,758 $331,000

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $199B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Astrazeneca PLC Transaction History